GoldenBiotech reports positive data from leukaemia drug trial
Taiwanese biopharma company Golden Biotechnology (GoldenBiotech) has reported that data from its Phase IIa clinical study conducted in Russia showed…
27 Nov 2020
Haoma Medica concludes trial of oral osteoporosis treatment
Clinical-stage biotech firm Haoma Medica has completed a first-in-human trial for novel orally administered therapeutic, NaQuinate, being developed for osteoporosis. Osteoporosis is often present without any signs or symptoms until…
27 Nov 2020
Antengene to begin Phase I/II trial of MDS monotherapy in China
Antengene is set to begin the Phase I/II clinical trial of ATG-016 (eltanexor) monotherapy in patients with intermediate and higher risk myelodysplastic syndrome (MDS). The latest development comes after the…
26 Nov 2020
Bharat Biotech begins Phase III trial of Covid-19 vaccine at AIIMS
Indian firm Bharat Biotech has initiated the Phase III human clinical trial of the anti-Covid-19 vaccine candidate, Covaxin, at the AIIMS. The company is developing Covaxin in partnership with the…
26 Nov 2020
NIH starts enrolment in fourth iteration of Covid-19 trial
The US National Institutes of Health (NIH) unit the National Institute of Allergy and Infectious Diseases (NIAID) has announced the commencement of Covid-19 patient enrolment in the fourth iteration of…
26 Nov 2020
Researchers conduct study to increase trial participation in New Zealand
A national team of expert clinicians and health researchers in New Zealand are leading a new study to make more people in the country participate in clinical trials. The team…
26 Nov 2020
Celltrion concludes enrolment in global Covid-19 antibody trial
Celltrion Group has completed enrolment of 327 patients with mild-to-moderate SARS-CoV-2 infection symptoms to evaluate anti-Covid-19 monoclonal antibody treatment candidate CT-P59 in the global Phase II clinical trial. CT-P59 was…